16 July 2025
Update on CARES Phase III clinical programme of anselamimab in light chain amyloidosis Results did not achieve statistical significance for the primary endpoint in…
Rio Tinto releases second quarter 2025 production results 16 July 2025 13% CuEq production uplift for Q2 YoY, and 6% for H1, as we…
15 July 2025
Trading update, first quarter 15 July 2025 ─ Experian plc, the global data and technology company, today issues an update on trading for the three…
Advanced Medical Solutions Group plc (“AMS” or the “Group”) Half Year Trading Update ~ Strong performance, integrations progressing well ~ Winsford, UK: Advanced Medical Solutions…
Concurrent Technologies Plc (the “Company” or the “Group”) Trading Update Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems…
GlobalData Plc (AIM: DATA, GlobalData, the Group) Trading Update GlobalData Plc, the leading data, insight, and technology company, today provides a Trading Update for…
14 July 2025
US FDA accepts application to review expanded use of GSK’s RSV vaccine, Arexvy, for adults 18-49 at increased risk GSK plc (LSE/NYSE: GSK) today…
Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension Baxdrostat demonstrated a…